Eleni Gerontiti

Eleni Gerontiti

Auto-generated profile, based on publicly available information

Eleni Gerontiti

Endocrine Unit and Diabetes Center, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2023 in Endocrine
Verified
Journal Article
Open access
PDF file
SPStavroula A. Paschou
Stavroula A. Paschou
ASAlmog Shalit
Almog Shalit
EGEleni Gerontiti
Eleni Gerontiti
KAKleoniki Athanasiadou
Kleoniki Athanasiadou
TKTheodoros Kalampokas
Theodoros Kalampokas
Dimitrios G. GoulisDimitrios G. Goulis
Dimitrios G. Goulis
During the last decades, gestational diabetes mellitus (GDM) prevalence has been on the rise. While insulin remains the gold standard treatment for GDM, metformin use during pregnancy is controversial. This review aimed to comprehensively assess the available data on the efficacy and safety of metformin during pregnancy, both for the mother and the offspring. Metformin has been validated for maternal efficacy and safety, achieving comparable glycemic control with insulin. Additionally, it reduces maternal weight gain and possibly the occurrence of hypertensive disorders. During the early neonatal period, metformin administration does not increase the risk of congenital anomalies or other major adverse effects, including lower APGAR score at 5 min, neonatal intensive care unit admissions, and respiratory distress syndrome. Several studies have demonstrated a reduction in neonatal hypoglycemia. Metformin has been associated with an increase in preterm births and lower birth weight, although this effect is controversial and depends on the indication for which it was administered. Evidence indicates possible altered fetal programming and predisposition to childhood obesity and metabolic syndrome during adulthood after use of metformin in pregnancy. With critical questions still requiring a final verdict, ongoing research on the field must be conducted.

12 February 2024 in Endocrine
Verified
Journal Article
Open access
PDF file
DKDimitra Karaviti
Dimitra Karaviti
EKEleni Rafaela Kani
Eleni Rafaela Kani
EKELEFTHERIA KARAVITI
ELEFTHERIA KARAVITI
EGEleni Gerontiti
Eleni Gerontiti
OMOlympia Michalopoulou
Olympia Michalopoulou
SPStavroula A. Paschou
Stavroula A. Paschou
Immune checkpoint inhibitors (ICIs) are a revolutionary class of drugs that powerfully contribute to cancer therapy by harnessing the immune system to fight malignancies. However, their successful use as anti-cancer drugs is accompanied by a wide spectrum of immune-related adverse effects (irAEs), including endocrinopathies. Among them, thyroid dysfunction stands out as one of the most common endocrinopathies induced by ICI therapy and surfaces as a prominent concern. Destructive thyroiditis is the pathophysiological basis shared by the most common patterns of thyrotoxicosis followed by hypothyroidism and isolated hypothyroidism. Diagnostic approach is guided by clinical manifestation, laboratory evaluation and imaging modalities. Treatment approaches range from the substitution of levothyroxine to the utilization of beta blockers, depending on the extent of thyroid dysfunction’s severity. While the medical community is dealing with the evolution and complexities of immunotherapy, recognizing and effectively managing ICI-induced thyroid dysfunction emerged as crucial for enhancing patient safety and achieving improved outcomes. The aim of this review is to navigate the significance of ICI-induced thyroid dysfunction unraveling the various patterns, underlying mechanisms, diagnostic approaches, and treatment strategies. It, also, highlights the impact of various factors such as cancer subtype, ICI dosage, age, and genetic susceptibility on the risk of experiencing dysfunction.

24 September 2024 in Endocrine
Verified
Journal Article
Closed access
PDF file
EKEleni Rafaela Kani
Eleni Rafaela Kani
EKELEFTHERIA KARAVITI
ELEFTHERIA KARAVITI
DKDimitra Karaviti
Dimitra Karaviti
EGEleni Gerontiti
Eleni Gerontiti
IPIoanna A. Paschou
Ioanna A. Paschou
SPStavroula A. Paschou
Stavroula A. Paschou